Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Presentation ACC 2023

Complete Revascularization Strategies in Patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease

Presenter: Roberto Diletti

March 05, 2023

Presentation SIF 2019

Complete revascularization in STEMI – what shall we do in 2019?

March 29, 2019

Presentation

Predictors and Outcomes of Staged vs One-Time Revascularization in Multivessel CAD

November 20, 2018

Presentation CHIP Seattle 2017

Yes, the Data Favor Invasive Management and Revascularization for These Patients (with Ischemic CM)

Presenter: Ajay J. Kirtane

August 10, 2017

Presentation

FFR-Guided Complete Revascularization in Patients With STEMI and Severe Nonculprit Disease

April 21, 2017

Presentation

Impact of Anticoagulation Regimen Prior toRevascularization in Patients With NSTE-ACS

Presenter: Tobias Geisler

September 18, 2015

Presentation

Concomitant PPI Use, Platelet Activity, and Clinical Outcomes in ACS Patients Treated With Prasugrel vs Clopidogrel and Managed Without Revascularization

Presenter: Jose Carlos Nicolau

June 17, 2015

Presentation

Ticagrelor vs Clopidogrel in Patients with NSTE-ACS With or Without Revascularization

Presenter: D. Lindholm

April 25, 2014

Presentation

Preoperative Statins and Limb Salvage after Lower Extremity Revascularization in the Medicare Population

Presenter: Todd R. Vogel

December 11, 2013

Presentation TCT 2013

Impact of Anti-anginal Therapy and Rate Pressure Product Control on the Need for Repeat Revascularization Post-PCI

Presenter: Subhash Banerjee, Rick Weideman, Bertis Little, Mark Weideman, Jennifer Gunter, Kevin Kelly, Emmanouil Brilakis

January 31, 2013

Presentation ESC 2012

Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial

Presenter: Matthew Roe

August 28, 2012

Presentation

Cilostazol Added to Aspirin and Clopidogrel Reduces Revascularization Without Increases in Major Adverse Events in Patients With DES

Presenter: Ryota Sakurai

July 12, 2012

Advertisement

Complete Revascularization Strategies in Patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease

Complete revascularization in STEMI – what shall we do in 2019?

Predictors and Outcomes of Staged vs One-Time Revascularization in Multivessel CAD

Yes, the Data Favor Invasive Management and Revascularization for These Patients (with Ischemic CM)

FFR-Guided Complete Revascularization in Patients With STEMI and Severe Nonculprit Disease

Impact of Anticoagulation Regimen Prior toRevascularization in Patients With NSTE-ACS

Concomitant PPI Use, Platelet Activity, and Clinical Outcomes in ACS Patients Treated With Prasugrel vs Clopidogrel and Managed Without Revascularization

Ticagrelor vs Clopidogrel in Patients with NSTE-ACS With or Without Revascularization

Preoperative Statins and Limb Salvage after Lower Extremity Revascularization in the Medicare Population

Impact of Anti-anginal Therapy and Rate Pressure Product Control on the Need for Repeat Revascularization Post-PCI

Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial

Cilostazol Added to Aspirin and Clopidogrel Reduces Revascularization Without Increases in Major Adverse Events in Patients With DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content